The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

omicsTools: Omics Data Process Toolbox

Processing and analyzing omics data from genomics, transcriptomics, proteomics, and metabolomics platforms. It provides functions for preprocessing, normalization, visualization, and statistical analysis, as well as machine learning algorithms for predictive modeling. 'omicsTools' is an essential tool for researchers working with high-throughput omics data in fields such as biology, bioinformatics, and medicine.The QC-RLSC (quality control–based robust LOESS signal correction) algorithm is used for normalization. Dunn et al. (2011) <doi:10.1038/nprot.2011.335>.

Version: 1.0.5
Imports: bs4Dash, config (≥ 0.3.1), dplyr, DT, golem (≥ 0.3.5), magrittr, readr, shiny (≥ 1.7.2), tibble
Suggests: spelling, testthat (≥ 3.0.0)
Published: 2023-07-03
DOI: 10.32614/CRAN.package.omicsTools
Author: Yaoxiang Li ORCID iD [cre, aut], Zihao Zhang [aut], Meth Jayatilake [aut], Amrita Cheema ORCID iD [aut]
Maintainer: Yaoxiang Li <liyaoxiang at outlook.com>
BugReports: https://github.com/YaoxiangLi/omicsTools/issues
License: MIT + file LICENSE
URL: https://github.com/YaoxiangLi/omicsTools
NeedsCompilation: no
Materials: README NEWS
CRAN checks: omicsTools results

Documentation:

Reference manual: omicsTools.pdf

Downloads:

Package source: omicsTools_1.0.5.tar.gz
Windows binaries: r-devel: omicsTools_1.0.5.zip, r-release: omicsTools_1.0.5.zip, r-oldrel: omicsTools_1.0.5.zip
macOS binaries: r-release (arm64): omicsTools_1.0.5.tgz, r-oldrel (arm64): omicsTools_1.0.5.tgz, r-release (x86_64): omicsTools_1.0.5.tgz, r-oldrel (x86_64): omicsTools_1.0.5.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=omicsTools to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.